Tin tức & Cập nhật

Tenofovir better than entecavir for minimizing HCC risk in HBV

23 Jan 2020

Tenofovir disoproxil fumarate (TDF) for hepatitis B virus (HBV) infection suppresses hepatocellular carcinoma (HCC) risk better than entecavir, a new study has found.

Tenofovir better than entecavir for minimizing HCC risk in HBV

23 Jan 2020

TURANDOT trials confirm efficacy of ontamalimab in inducing remission in UC patients

23 Jan 2020 bởi

The TURANDOT* and TURANDOT II** studies confirm the efficacy of the monoclonal immunoglobulin G2 anti-MAdCAM-1*** antibody ontamalimab to induce remission in patients with ulcerative colitis (UC).

TURANDOT trials confirm efficacy of ontamalimab in inducing remission in UC patients

23 Jan 2020

Coffee consumption does not raise uric acid levels

23 Jan 2020

Coffee drinkers do not appear to have elevated serum uric acid levels compared with nondrinkers, a study has found.

Coffee consumption does not raise uric acid levels

23 Jan 2020

Study suggests dupilumab QW/Q2W dose as maintenance for atopic dermatitis

22 Jan 2020 bởi

A 300 mg QW or Q2W maintenance dupilumab regimen is less likely to result in worsening of atopic dermatitis (AD) than switching to a Q4W or Q8W regimen, results of the phase III LIBERTY AD SOLO-CONTINUE* trial show.

Study suggests dupilumab QW/Q2W dose as maintenance for atopic dermatitis

22 Jan 2020

Tofacitinib may not benefit EIMs in ulcerative colitis

22 Jan 2020 bởi

The oral Janus kinase inhibitor tofacitinib appears to have no benefit for the extraintestinal manifestations* (EIMs) of moderate-to-severe ulcerative colitis (UC), according to data from the OCTAVE** clinical programme presented at AIBD 2019.

Tofacitinib may not benefit EIMs in ulcerative colitis

22 Jan 2020

Immunoglobulin holds promise for treatment-resistant polyneuropathy in diabetics

22 Jan 2020 bởi

Treatment with intravenous immunoglobulin (IVIG) offers significant pain relief in patients with painful diabetic polyneuropathy (DPN) resistant to standard therapies, without deleterious side effects, according to the results of a trial.

Immunoglobulin holds promise for treatment-resistant polyneuropathy in diabetics

22 Jan 2020

Delafloxacin noninferior to moxifloxacin for community-acquired bacterial pneumonia

21 Jan 2020 bởi

Delafloxacin appears noninferior to moxifloxacin in the treatment of community-acquired bacterial pneumonia (CABP), according to the phase III DEFINE-CABP* study.

Delafloxacin noninferior to moxifloxacin for community-acquired bacterial pneumonia

21 Jan 2020

Anakinra effective against macrophage activation syndrome

21 Jan 2020

Treatment with anakinra appears beneficial to children with secondary haemophagocytic lymphohistiocytosis (HLH)/macrophage activation syndrome (MAS), especially when administered early in the disease course and to those who have an underlying rheumatic disease, as shown in a study.

Anakinra effective against macrophage activation syndrome

21 Jan 2020

Infliximab infusions proven safe, effective in paediatric patients with acute Kawasaki disease

21 Jan 2020 bởi

A single infusion of infliximab effectively resolves fever in paediatric patients with acute Kawasaki disease (KD) refractory to conventional therapies, a Japan study performed in the real-world clinical setting has shown. In addition, it is well tolerated, with no new safety concerns seen.

Infliximab infusions proven safe, effective in paediatric patients with acute Kawasaki disease

21 Jan 2020

Fingolimod shows favourable benefit-risk profile in MS patients switching from natalizumab

21 Jan 2020 bởi

Subgroup analysis of the PANGAEA* study underlines the long-term efficacy and safety of fingolimod for over 48 months in patients with multiple sclerosis (MS) after switching from natalizumab.

Fingolimod shows favourable benefit-risk profile in MS patients switching from natalizumab

21 Jan 2020

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Tenofovir better than entecavir for minimizing HCC risk in HBV

Tenofovir better than entecavir for minimizing HCC risk in HBV

TURANDOT trials confirm efficacy of ontamalimab in inducing remission in UC patients

TURANDOT trials confirm efficacy of ontamalimab in inducing remission in UC patients

Coffee consumption does not raise uric acid levels

Coffee consumption does not raise uric acid levels

Study suggests dupilumab QW/Q2W dose as maintenance for atopic dermatitis

Study suggests dupilumab QW/Q2W dose as maintenance for atopic dermatitis

Tofacitinib may not benefit EIMs in ulcerative colitis

Tofacitinib may not benefit EIMs in ulcerative colitis

Immunoglobulin holds promise for treatment-resistant polyneuropathy in diabetics

Immunoglobulin holds promise for treatment-resistant polyneuropathy in diabetics

Delafloxacin noninferior to moxifloxacin for community-acquired bacterial pneumonia

Delafloxacin noninferior to moxifloxacin for community-acquired bacterial pneumonia

Anakinra effective against macrophage activation syndrome

Anakinra effective against macrophage activation syndrome

Infliximab infusions proven safe, effective in paediatric patients with acute Kawasaki disease

Infliximab infusions proven safe, effective in paediatric patients with acute Kawasaki disease

Fingolimod shows favourable benefit-risk profile in MS patients switching from natalizumab

Fingolimod shows favourable benefit-risk profile in MS patients switching from natalizumab